Glucagon-Like Peptide-1 Increases Mitochondrial Biogenesis and Function in INS-1 Rat Insulinoma Cells.
10.3803/EnM.2015.30.2.216
- Author:
Mi Yeon KANG
1
;
Tae Jung OH
;
Young Min CHO
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. ymchomd@snu.ac.kr
- Publication Type:Brief Communication
- Keywords:
Glucagon-like peptide-1;
Mitochondria;
Diabetes mellitus;
Beta cell;
Insulin
- MeSH:
Animals;
Diabetes Mellitus;
Glucagon-Like Peptide 1*;
Incretins;
Insulin;
Insulinoma*;
Membrane Potential, Mitochondrial;
Mitochondria;
Organelle Biogenesis*;
Oxygen Consumption;
Rats*
- From:Endocrinology and Metabolism
2015;30(2):216-220
- CountryRepublic of Korea
- Language:English
-
Abstract:
Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that increases glucose-stimulated insulin secretion in pancreatic beta-cells. Since mitochondrial function is crucial to insulin secretion, we hypothesized that GLP-1 may increase mitochondrial biogenesis in pancreatic beta-cells. We treated INS-1 rat insulinoma cells with GLP-1 or exendin-4 for 48 hours and measured mitochondrial mass and function. Both GLP-1 and exendin-4 increased mitochondrial mass by approximately 20%. The mitochondria/cytosol ratio was increased from 7.60+/-3.12% to 10.53+/-2.70% by exendin-4. In addition, GLP-1 increased the mitochondrial membrane potential and oxygen consumption. Proliferator-activated receptor-gamma coactivator 1alpha expression was increased approximately 2-fold by GLP-1 treatment. In conclusion, the present study presents evidence for a new mechanism of action by which GLP-1 improves pancreatic beta-cell function via enhanced mitochondrial mass and performance.
